Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 1,517 | 1,517 | 1,517 | 2,108 | 1,220 |
| Gross Profit | 1,517 | 1,517 | 1,517 | 2,108 | 1,220 |
| Operating Expenses | 72,940 | 59,056 | 77,393 | 64,062 | 44,986 |
| Operating Income | -71,423 | -57,539 | -75,876 | -61,954 | -43,766 |
| Interest Expense | 2,357 | 0 | 0 | 0 | 0 |
| Other Income | 622 | 1,492 | 1,915 | 1,152 | -706 |
| Pre-tax Income | -73,158 | -56,047 | -73,961 | -60,802 | -44,472 |
| Net Income Continuous | -73,158 | -56,047 | -73,961 | -60,802 | -44,472 |
| Net Income | $-73,158 | $-56,047 | $-73,961 | $-60,802 | $-44,472 |
| EPS Basic Total Ops | -1.87 | -1.84 | -2.92 | -2.90 | -3.22 |
| EPS Basic Continuous Ops | -1.77 | -1.84 | -2.92 | -2.90 | -3.04 |
| EPS Diluted Total Ops | -1.87 | -1.84 | -2.92 | -2.90 | -3.22 |
| EPS Diluted Continuous Ops | -1.77 | -1.84 | -2.92 | -2.90 | -3.04 |
| EPS Diluted Before Non-Recurring Items | -1.87 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-71,464 | $-58,227 | $-76,356 | $-61,655 | $-43,803 |